Document Type

Article

Publication Date

3-22-2022

Publication Title

Cephalalgia

Abstract

Background: Headaches with marked, specific response to indomethacin occur in children, but the phenotypic spectrum of this phenomenon has not been well-studied. Methods: We reviewed pediatric patients with headache showing ≥80% improvement with indomethacin, from seven academic medical centers. Results: We included 32 pediatric patients (16 females). Mean headache onset age was 10.9 y (range 2–16 y). Headache syndromes included hemicrania continua (n = 13), paroxysmal hemicrania (n = 10), primary stabbing headache (n = 2), short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing (n = 1), primary exercise headache (n = 1) and primary cough headache (n = 1). Adverse events were reported in 13, most commonly gastrointestinal symptoms, which often improved with co-administration of gastro-protective agents. Conclusion: Indomethacin-responsive headaches occur in children and adolescents, and include headache syndromes, such as primary cough headache, previously thought to present only in adulthood. The incidence of adverse events is high, and patients must be co-treated with a gastroprotective agent.

First Page

793

Last Page

797

PubMed ID

35302385

Volume

42

Issue

8

File Format

pdf

File Size

440 KB

Included in

Neurology Commons

Share

COinS